Indian Priority Pathogen List jointly developed by DBT and WHO India Office

  18 March 2021

Antimicrobial resistance (AMR) is one of the top 10 global health threat faced by the world
today and can have a major impact on the economy, society, food safety and public health.
Infections caused by antibiotic-resistant pathogens substantially amplify the burden of both
healthcare-associated and community-acquired infections. To minimize the emergence and
spread of AMR, coordinated actions are required at the global, national and sub-national
levels.

The objectives of the IPPL are to
• guide the prioritization of research on AMR, including incentives and funding;
• help align R&D priorities with Indian public health needs; and
• support India’s leadership in containment of antibiotic resistant bacteria.
The IPPL shall be useful for policy initiatives to incentivise basic science and advanced R&D by
both public funding agencies and the private sector investing in new antibiotics.

Further reading: Government of India
Author(s): Ministry of Science & Technology
Effective Surveillance   Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed